Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 2.3. It has been cited 77 times, with 66 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.654
From this paper's citation signal
Citation Network Contribution
1.7
From 53 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 66 citers.
National Institutes of Health
Grant: UL1TR002494
National Institutes of Health
Grant: P30 CA77598
NCI NIH HHS
Grant: P30 CA077598
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: P30 CA014236
MeSH Terms
Keywords
Additional file 1 of Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients
Additional file 1 of Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients